Concepedia

Publication | Open Access

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

DOIFull Paper Access

54

Citations

42

References

2018

Year

Veronique L. Veenstra, Helene Damhofer, Cynthia Waasdorp, L. Bengt van Rijssen, Marc J. van de Vijver, Frederike Dijk, Hanneke Wilmink, Marc G. Besselink, Olivier R. Busch, David K. Chang,
Oncogenesis

References

YearCitations

Page 1